As VCaPER show similarly increased mitochondrial activity and quantities, further research will need to assess if this role for GDAP1 is conserved in PCa, or if affecting its expression could represent a therapeutic option for combatting ENZ resistance. The gene discussed is GDAP1; the disease is posterior cortical atrophy.